These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 22211826)

  • 1. Successful switch-over administration of intravenous-to-oral tacrolimus after isolated living-donor liver transplantation in a child with ultra short gut syndrome.
    Koike Y; Uchida K; Kusunoki M
    Transpl Int; 2012 Feb; 25(2):e29-30. PubMed ID: 22211826
    [No Abstract]   [Full Text] [Related]  

  • 2. Once-daily tacrolimus in living donor liver transplant recipients.
    Sugawara Y; Miyata Y; Kaneko J; Tamura S; Aoki T; Sakamoto Y; Hasegawa K; Yamashiki N; Kokudo N
    Biosci Trends; 2011 Aug; 5(4):156-8. PubMed ID: 21914950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of oral tacrolimus in a case of short bowel syndrome.
    Patel N; Smith S; Handa A; Darby C
    Transpl Int; 2004 Jan; 17(1):44-5. PubMed ID: 12955349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living donor liver transplant recipients achieve relatively higher immunosuppressant blood levels than cadaveric recipients.
    Trotter JF; Stolpman N; Wachs M; Bak T; Kugelmas M; Kam I; Everson GT
    Liver Transpl; 2002 Mar; 8(3):212-8. PubMed ID: 11910565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
    Fukudo M; Yano I; Yoshimura A; Masuda S; Uesugi M; Hosohata K; Katsura T; Ogura Y; Oike F; Takada Y; Uemoto S; Inui K
    Pharmacogenet Genomics; 2008 May; 18(5):413-23. PubMed ID: 18408564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral absorption of tacrolimus in children with intestinal failure due to short or absent small bowel.
    Novelli M; Muiesan P; Mieli-Vergani G; Dhawan A; Rela M; Heaton ND
    Transpl Int; 1999; 12(6):463-5. PubMed ID: 10654359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients.
    Taber DJ; Dupuis RE; Fann AL; Andreoni KA; Gerber DA; Fair JH; Johnson MW; Shrestha R
    Liver Transpl; 2002 Mar; 8(3):219-23. PubMed ID: 11910566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation.
    Fukudo M; Yano I; Shinsako K; Katsura T; Takada Y; Uemoto S; Inui K
    J Clin Pharmacol; 2009 Jul; 49(7):789-97. PubMed ID: 19487492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradycardia associated with intravenous administration of tacrolimus in a liver transplant recipient.
    Cox TH; Baillie GM; Baliga P
    Pharmacotherapy; 1997; 17(6):1328-30. PubMed ID: 9399620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient.
    Hernández G; Jiménez C; Arriba L; Moreno E; Lucas M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Nov; 92(5):526-31. PubMed ID: 11709689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantation.
    Fukudo M; Yano I; Fukatsu S; Saito H; Uemoto S; Kiuchi T; Tanaka K; Inui K
    Clin Pharmacokinet; 2003; 42(13):1161-78. PubMed ID: 14531726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset of tacrolimus-related posterior leukoencephalopathy after living donor liver transplantation.
    Frühauf NR; Koeppen Dagger S; Saner FH; Egelhof Dagger T; Stavrou G; Nadalin S; Broelsch CE
    Liver Transpl; 2003 Sep; 9(9):983-5. PubMed ID: 12942462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeating intraportal donor-specific transfusion may induce tolerance following adult living-related donor liver transplantation.
    Sato Y; Ichida T; Watanabe H; Yamamoto S; Oya H; Nakatsuka H; Kobayashi T; Watanabe T; Kameyama H; Hatakeyama K
    Hepatogastroenterology; 2003; 50(51):601-6. PubMed ID: 12828042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of living donor liver transplant patients using twice-daily 4-hour intravenous cyclosporine therapy.
    Sato K; Iwane T; Sekiguchi S; Nakamura A; Akamatsu Y; Kawagishi N; Miyagi S; Takeda I; Sato A; Fujimori K; Satomi S
    Transplant Proc; 2009; 41(1):229-32. PubMed ID: 19249521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
    Fukudo M; Yano I; Masuda S; Fukatsu S; Katsura T; Ogura Y; Oike F; Takada Y; Tanaka K; Inui K
    Clin Pharmacol Ther; 2005 Aug; 78(2):168-81. PubMed ID: 16084851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunosuppression and the problems in partial liver transplantation].
    Kawasaki M; Hashikura Y; Matsunami H; Makunouchi M
    Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):683. PubMed ID: 8963785
    [No Abstract]   [Full Text] [Related]  

  • 19. Leukoencephalopathy syndrome after living-donor liver transplantation.
    Umeda Y; Matsuda H; Sadamori H; Shinoura S; Yoshida R; Sato D; Utsumi M; Yagi T; Fujiwara T
    Exp Clin Transplant; 2011 Apr; 9(2):139-44. PubMed ID: 21453233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living-related intestinal transplantation for a patient with hypoganglionosis.
    Ishii T; Wada M; Nishi K; Kazama T; Kawahara Y; Sasaki H; Amae S; Yoshida S; Nakamura M; Nio M; Kato T; Hayashi Y
    Pediatr Transplant; 2006 Mar; 10(2):244-7. PubMed ID: 16573615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.